Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review.
Manyara AM, Davies P, Stewart D, Weir CJ, Young AE, Wells V, Blazeby J, Butcher NJ, Bujkiewicz S, Chan AW, Collins GS, Dawoud D, Offringa M, Ouwens M, Ross JS, Taylor RS, Ciani O.
Manyara AM, et al. Among authors: taylor rs.
J Clin Epidemiol. 2023 Aug;160:83-99. doi: 10.1016/j.jclinepi.2023.06.013. Epub 2023 Jun 26.
J Clin Epidemiol. 2023.
PMID: 37380118
Free article.
Review.